Intravitreal triamcinolone acetonide for acute radiation papillopathy

Retina

Volumn 26, Issue 5, 2006, Pages 537-544

  Shields, Carol L ^a,b   Demirci, Hakan ^a   Marr, Brian P ^a   Mashayekhi, Arman ^a   Dai, Vicktoria V ^a   Materin, Miguel A ^a   Shields, Jerry A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WILLS EYE HOSPITAL   (United States)

Author keywords

Choroid; Melanoma; Papillopathy; Radiation; Treatment; Triamcinolone acetonide

Indexed keywords

TRIAMCINOLONE; GLUCOCORTICOID; RADIOACTIVE IODINE; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CHOROID MELANOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; EYE EDEMA; FEMALE; HUMAN; HYPEREMIA; IRIS; MALE; OPTIC DISK; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INDUCED PAPILLOPATHY; RETINA; RETINA HEMORRHAGE; RETINA MACULA EDEMA; RETINA MACULOPATHY; RETINOPATHY; TREATMENT OUTCOME; VISUAL ACUITY; ACUTE DISEASE; BRACHYTHERAPY; CHOROID TUMOR; INJECTION; MELANOMA; MIDDLE AGED; OPTIC NERVE DISEASE; RADIATION EXPOSURE; RADIATION INJURY; RETINA DISEASE; VITREOUS BODY;

ACUTE DISEASE; ADULT; AGED; BRACHYTHERAPY; CHOROID NEOPLASMS; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; IODINE RADIOISOTOPES; MALE; MELANOMA; MIDDLE AGED; OPTIC DISK; OPTIC NERVE DISEASES; PROSPECTIVE STUDIES; RADIATION INJURIES; RETINAL DISEASES; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 33745800936     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200605000-00007     Document Type: Article

References (32)

1. Shields JA, Shields CL, Donoso LA. Management of posterior uveal melanoma. Surv Ophthalmol 1991;36:161-195.
2. Shields CL, Shields JA, Gunduz K, et al. Radiation therapy for uveal malignant melanoma. Ophthalmic Surg Las 1998;29:397-409.
3. Lommatzsch PK, Werschnik C, Schuster E. Long term follow up of Ru 106/ Rh 106 brachytherapy for posterior uveal melanoma. Graefes Arch Clin Exp Ophthalmol 2000;238:129-137.
4. Diener-West M, Earle JD, Fine SL, et al. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma III: initial mortality findings. COMS report no. 18. Arch Ophthalmol 2001;119:1067-1068.
5. Shields JA, Shields CL. Management of posterior uveal melanoma. In: Intraocular Tumors. A Text and Atlas. Philadelphia: WB Saunders; 1992:171-206.
6. Shields JA, Shields CL. Management of posterior uveal melanoma. Atlas of Intraocular Tumors. Philadelphia: Lippincott Williams & Wilkins; 1999:113-140.
7. Wilson MW, Hungerford JL. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology 1999;106:1579-1587.
8. Shields CL, Cater J, Shields JA, et al. Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma in 270 consecutive patients. Arch Ophthalmol 2002;120:933-940.
9. Jampol LM, Moy CS, Murray TG, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology 2002;109:2197-2206.
10. Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for uveal melanoma. Long-term visual outcome in 1106 patients. Arch Ophthalmol 2000;118:1219-1228.
11. Gunduz K, Shields CL, Shields JA, et al. Radiation retinopathy following plaque radiotherapy of posterior uveal melanoma. Arch Ophthalmol 1999;117:609-614.
12. Gunduz K, Shields CL, Shields JA, et al. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 1999;127:579-589.
13. DePotter P, Shields CL, Shields JA, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome. Arch Ophthalmol 1996;114:1357-1365.
14. Gragoudas ES, Li W, Lane AM, et al. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology 1999;106:1571-1577; discussion 1577-1578.
15. Brown GC, Shields JA, Sanborn G, et al. Radiation optic neuropathy. Ophthalmology 1982;89:1489-1493.
16. Bernstein M, Ginsberg H, Glen J. Protection of iodine-125 brachytherapy brain injury in the rat with the 21-aminosteroid U-74389F. Neurosurgery 1992;31:923-928.
17. Tada E, Matsumoto K, Kinoshita K, et al. The protective effect of dexamethasone against radiation damage by interstitial irradiation in normal monkey brain. Neurosurgery 1997;41:209-219.
18. Kondziolka D, Somaza S, Martinez AJ, et al. Radioprotective effects of the 21-aminosteroid U-74389G for stereotactic radiosurgery. Neurosurgery 1997;41:203-208.
19. Leibel SA, Gutin PH, Wara WM, et al. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 1989;17:1129-1139.
20. Bernstein M, Cabantog AM, Glen J, et al. Tirilazad does not protect rat brain from brachytherapy-induced injury. Surg Neurol 1996;45:482.
21. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927.
22. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57-61.
23. Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247-248.
24. Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol 2002;120:1217-1219.
25. Benhamou N, Massin P, Hauchine B, et al. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 2003;135:246-249.
26. Scott IU, Flynn HW, Rosenfeld PJ. Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema. Am J Ophthalmol 2003;136:737-739.
27. Laby DM, Leavitt JA, King LM Jr. Steroid treatment of radiation-induced choroidopathy. Ann Ophthalmol 1993;25:180-181.
28. Sutter FK, Gillies MC. Intravitreal triamcinolone for radiation-induced macular edema. Arch Ophthalmol 2003;121:1491-1493.
29. Gould ES, Bird AC, Leaver PK, McDonald WI. Treatment of optic neuritis by retrobulbar injection of triamcinolone. BMJ 1977;1 (6075):1495-1497.
30. Tomsak RL, Lystad LD, Katirji MB, Brassel TC. Rapid response of syphilitic optic neuritis to posterior sub-Tenon's steroid injection. J Clin Neuroophthalmol 1992;12:6-7; discussion 8-9.
31. Molk R. Treatment of toxocaral optic neuritis. J Clin Neuroophthalmol 1982;2:109-112.
32. Al-Haddad CE, Jurdi FA, Bashshur ZF. Intravitreal triamcinolone acetonide for the management of diabetic papillopathy. Am J Ophthalmol 2004;137:1151-1153.